Hemochron Jr. Citrate APTT Cuvette 510(k) K014008 A unitized microcoagulation test intended to be used in performing a quantitative, one -stage APTT. The citrate APTT test is used for evaluation of low doses of heparin anticoagulant (up to 1.5 units/mL), depending upon individual patient heparin sensitivity.
Published February 12, 2014 · Recall initiated: December 19, 2013
Summary
FDA records medical device Class II recall Z-0937-2014, published February 12, 2014 and initiated December 19, 2013. Recalling firm: ITC-Nexus Dx; Status: Terminated; Reported quantity: 25,965 curvettes (7,425 cuvettes US; 18,540 cuvettes OUS); Lot: E3JCC013-P1 - exp 2014-05 E3JCC014-P2 - exp - 2014-05 F3JCC015-P3 - exp -2014-06 F3JCC016 - exp - 2014-06 H3JCC017 - exp - 2014-08. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
ITC has determined that some Citrate APTT cuvettes may recover higher than expected results in normal individuals.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ITC-Nexus Dx
- Distributor
- Worldwide Distribution: US (nationwide) and countries of: Austria, Belgium, Canada, Serbia, Germany, Estonia, Italy, Spain and Saudia Arabia.
- Lot
- E3JCC013-P1 - exp 2014-05 E3JCC014-P2 - exp - 2014-05 F3JCC015-P3 - exp -2014-06 F3JCC016 - exp - 2014-06 H3JCC017 - exp - 2014-08
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAHemochron Jr. Whole Blood Microcoagulation System APTT Cuvette. For in vitro diagnostic coagulation test.July 30, 2014
- FDAOxcarbazepine Tablets, 300 mg, 100 tablet bottles, Rx Only. Distributed by: Caraco PharmaceuticalFebruary 19, 2014
- FDADiclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only,February 19, 2014
- FDAThe Symbionic Leg is an integrated prosthetic leg for transfemoral and knee disarticulation amputees. TheFebruary 12, 2014
- FDALOCATOR® Implant Attachment System. The LOCATOR® Implant Attachment System is a universal hinge, resilientFebruary 12, 2014
- FDASurgicutt fully automated incision making device for bleeding time determination. ITC 8 Olsen Avenue, Edison,November 13, 2013
Questions about this recall
Was Hemochron Jr. Citrate APTT Cuvette 510(k) K014008 A unitized microcoagulation test intended to be used in performing a quantitative, one -stage APTT. The citrate APTT test is used for evaluation of low doses of heparin anticoagulant (up to 1.5 units/mL), depending upon individual patient heparin sensitivity. recalled?
Yes. FDA published recall Z-0937-2014 on February 12, 2014. Reported hazard: ITC has determined that some Citrate APTT cuvettes may recover higher than expected results in normal individuals.
What should I do if I have this product?
Voluntary: Firm initiated · Letter